Barriers to conducting deprescribing in the elderly population amid the COVID-19 pandemic

Deprescribing aims to reduce polypharmacy, especially in the elderly population, in order to maintain or improve quality of life, reduce harm from medications, and limit healthcare expenditure. Coronavirus disease (COVID-19) is an infectious disease that has led to a pandemic and has changed the liv...

Descripción completa

Detalles Bibliográficos
Autores principales: Elbeddini, Ali, Prabaharan, Thulasika, Almasalkhi, Sarah, Tran, Cindy, Zhou, Yueyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256521/
https://www.ncbi.nlm.nih.gov/pubmed/32499161
http://dx.doi.org/10.1016/j.sapharm.2020.05.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256521/
https://www.ncbi.nlm.nih.gov/pubmed/32499161
http://dx.doi.org/10.1016/j.sapharm.2020.05.025

Ejemplares similares